Skip to Main content Skip to Navigation
Journal articles

Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice

Abstract : We have considered the in vivo striatal binding of two ligands of the neuronal dopamine uptake complex [3H]cocaine and [3H]mazindol. The [3H]cocaine tracer dose labelled the dopamine uptake complex in striatum but not the noradrenaline complex in cerebellum. On the contrary, the [3H]mazindol tracer dose induced a marked labelling of the noradrenaline uptake complex in cerebellum; its prevention by desipramine (5 mg/kg) increased simultaneously the cerebral bioavailability and thereby the striatal labelling of the dopamine transporter. In mice submitted to treatments modifying dopaminergic transmission either to decrease it (gammabutyrolactone, 750 mg/kg, i.p.) or to increase it (L-DOPA, 200 mg/kg, i.p., dexamphetamine, 4 mg/kg, s.c., or their combination), only dexamphetamine pretreatment significantly reduced [3H]cocaine and [3H]mazindol binding. Thus it appears that the level of dopamine transmission would not interfere with the in vivo quantification of striatal dopamine uptake sites assessed with either ligands.
Document type :
Journal articles
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-02186987
Contributor : Université Normandie <>
Submitted on : Wednesday, July 17, 2019 - 3:29:59 PM
Last modification on : Friday, February 7, 2020 - 4:30:04 PM

Links full text

Identifiers

Collections

Citation

F Thibaut, J J Bonnet, J. M. Vaugeois, J Costentin. Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice. Neuroscience Letters, Elsevier, 1996, 205 (3), pp.145-8. ⟨10.1016/0304-3940(96)12399-5⟩. ⟨hal-02186987⟩

Share

Metrics

Record views

39